Advertisement
Screener

IVERIC bio, Inc. Net Cash Provided by (Used in) Operating Activities, Continuing Operations

IVERIC bio, Inc. Net Cash Provided by (Used in) Operating Activities, Continuing Operations

IVERIC bio, Inc. reported Net Cash Provided by (Used in) Operating Activities, Continuing Operations of -$61.51 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-03.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations · last filed 2017-05-03

  • IVERIC bio, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2017-03-31 was -$61.51M.
  • IVERIC bio, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-12-31 was -$32.81M.
  • IVERIC bio, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-09-30 was -$5.82M.
  • IVERIC bio, Inc. net cash provided by (used in) operating activities, continuing operations for the quarter ending 2016-06-30 was -$33.22M, a 309.82% decline year-over-year.
  • IVERIC bio, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2016 was -$108.60M.
  • IVERIC bio, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2015 was -$78.53M, a 170.69% decline from fiscal 2014.
  • IVERIC bio, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2014 was $111.09M.
  • IVERIC bio, Inc. net cash provided by (used in) operating activities, continuing operations for fiscal 2013 was -$48.77M.
Period endNet Cash Provided by (Used in) Operating Activities, Continuing Operations 3 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 6 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 9 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 12 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 81 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 84 monthNet Cash Provided by (Used in) Operating Activities, Continuing Operations 87 month
2017-03-31-$61.51M
10-Q · filed 2017-05-03
-$94.32M
derived: sum of 2 quarters · filed 2017-05-03
-$100.14M
derived: sum of 3 quarters · filed 2017-05-03
-$133.37M
derived: sum of 4 quarters · filed 2017-05-03
2016-12-31-$32.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
-$38.63M
derived: sum of 2 quarters · filed 2017-02-28
-$71.86M
derived: sum of 3 quarters · filed 2017-02-28
-$108.60M
10-K · filed 2017-02-28
2016-09-30-$5.82M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08
-$39.05M
derived: sum of 2 quarters · filed 2016-11-08
-$75.78M
10-Q · filed 2016-11-08
-$114.82M
derived: sum of 4 quarters · filed 2017-05-03
2016-06-30-$33.22M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05
-$69.96M
10-Q · filed 2016-08-05
-$109.00M
derived: sum of 3 quarters · filed 2017-05-03
-$132.82M
derived: sum of 4 quarters · filed 2017-05-03
2016-03-31-$36.74M
10-Q · filed 2017-05-03
-$75.78M
derived: sum of 2 quarters · filed 2017-05-03
-$99.60M
derived: sum of 3 quarters · filed 2017-05-03
-$83.76M
derived: sum of 4 quarters · filed 2017-05-03
2015-12-31-$39.04M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
-$62.86M
derived: sum of 2 quarters · filed 2017-02-28
-$47.02M
derived: sum of 3 quarters · filed 2017-02-28
-$78.53M
10-K · filed 2017-02-28
2015-09-30-$23.82M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08
-$7.99M
derived: sum of 2 quarters · filed 2016-11-08
-$39.49M
10-Q · filed 2016-11-08
-$28.73M
derived: sum of 4 quarters · filed 2017-02-28
2015-06-30$15.83M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05
-$15.68M
10-Q · filed 2016-08-05
-$4.91M
derived: sum of 3 quarters · filed 2017-02-28
-$49.53M
derived: sum of 4 quarters · filed 2017-02-28
2015-03-31-$31.51M
10-Q · filed 2016-05-09
-$20.74M
derived: sum of 2 quarters · filed 2017-02-28
-$65.37M
derived: sum of 3 quarters · filed 2017-02-28
$95.72M
derived: sum of 4 quarters · filed 2017-02-28
2014-12-31$10.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28
-$33.86M
derived: sum of 2 quarters · filed 2017-02-28
$127.23M
derived: sum of 3 quarters · filed 2017-02-28
$111.09M
10-K · filed 2017-02-28
2014-09-30-$44.63M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05
$116.47M
derived: sum of 2 quarters · filed 2015-11-05
$100.32M
10-Q · filed 2015-11-05
$74.74M
derived: sum of 4 quarters · filed 2016-02-26
2014-06-30$161.09M
derived: 10-Q 6 month − 10-Q/A 3 month · filed 2015-08-10
$144.95M
10-Q · filed 2015-08-10
$119.37M
derived: sum of 3 quarters · filed 2016-02-26
$106.61M
derived: sum of 4 quarters · filed 2016-02-26
2014-03-31-$16.15M
10-Q/A · filed 2015-07-28
-$41.72M
derived: sum of 2 quarters · filed 2016-02-26
-$54.49M
derived: sum of 3 quarters · filed 2016-02-26
-$61.39M
derived: sum of 4 quarters · filed 2016-02-26
-$152.71M
10-Q · filed 2014-05-13
2013-12-31-$25.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
-$38.34M
derived: sum of 2 quarters · filed 2016-02-26
-$45.24M
derived: sum of 3 quarters · filed 2016-02-26
-$48.77M
10-K · filed 2016-02-26
-$136.56M
10-K · filed 2014-03-11
2013-09-30-$12.76M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12
-$19.66M
derived: sum of 2 quarters · filed 2014-11-12
-$23.20M
10-Q · filed 2014-11-12
-$27.05M
derived: sum of 4 quarters · filed 2015-07-28
-$110.99M
10-Q · filed 2013-11-13
2013-06-30-$6.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06
-$10.44M
10-Q · filed 2014-08-06
-$14.29M
derived: sum of 3 quarters · filed 2015-07-28
2013-03-31-$3.53M
10-Q · filed 2014-05-13
-$7.39M
derived: sum of 2 quarters · filed 2015-07-28
2012-12-31-$3.85M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2015-07-28
-$13.10M
10-K/A · filed 2015-07-28
2012-09-30-$9.25M
10-Q · filed 2013-11-13
2011-12-31-$19.12M
10-K · filed 2014-03-11